On November 30, 2017 the U.S. Postal Service issued the first ever Alzheimer’s Disease Research Semipostal Stamp. The stamp was issued under the Semipostal Authorization Act, which grants the U.S. Postal Service discretionary authority to issue and sell semipostal stamps to advance causes it considers to be ‘‘in the national public interest and appropriate.’’
Semipostal stamps, currently sold for 60 cents, are First-Class Mail (FCM) postage stamps that are issued and sold at a price above the FCM rate to raise funds for designated causes. Revenue from sales of the stamp minus the postage paid and the reimbursement of reasonable costs incurred by the USPS will go to the National Institutes of Health to search for better treatments, prevention, and a cure for Alzheimer’s.
The Alzheimer’s Stamp is similar to the very popular and successful Breast Cancer Research Semipostal Stamp which, as of October 2017, has raised over $86.7 million for breast cancer research. The Alzheimer’s Semipostal stamp is intended to be sold for a two-year period, but legislation has been introduced in the House and the Senate that would allow an extension for six more years.
The stamps are available at most Post Offices, online at usps.com, and by toll-free phone order at 1-800 STAMP-24.
Get updates on the latest news in the senior living community.